Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH
- PMID: 2176309
- DOI: 10.1016/0167-0115(90)90111-9
Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH
Abstract
Corticotropin-releasing hormone (CRH) has been found in both hypothalamic and extrahypothalamic sites of the brain and also in the adrenal medulla. To study the timing and location of delayed glucocorticoid action in rats, we measured the effects of 2-day and 7-day cortisol treatment on immunoreactive CRH concentrations in hypothalamus, cerebral cortex, hippocampus, cerebellum, and adrenal gland. The activity of the hypothalamo-pituitary-adrenal (HPA) axis and the sympathoadrenal system were also measured. Studies were carried out both in the afternoon and/or in the morning, to get information about possible circadian changes. CRH contents were not changed in any brain areas studied, except there was a trend of decrease in the hypothalamus compared to vehicle in the afternoon due to the lack of circadian increase after 7-day cortisol treatment. Pituitary ACTH content decreased significantly after 7-day treatment, while beta-endorphin did not. Plasma levels of ACTH, corticosterone, norepinephrine and epinephrine and adrenal ACTH and beta-endorphin contents decreased after 2-day, adrenal CRH content after 7-day treatment with cortisol. Our findings suggest, that chronic cortisol treatment inhibits the circadian activation of the HPA axis at all levels but has variable effects on baseline measures because it causes different changes in release and synthesis at different sites.
Similar articles
-
Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.Endocrinology. 1996 Nov;137(11):4935-43. doi: 10.1210/endo.137.11.8895366. Endocrinology. 1996. PMID: 8895366
-
Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.Brain Res. 2003 Feb 28;964(2):187-99. doi: 10.1016/s0006-8993(02)03929-x. Brain Res. 2003. PMID: 12576179
-
Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.Endocrinology. 1990 Oct;127(4):1574-9. doi: 10.1210/endo-127-4-1574. Endocrinology. 1990. PMID: 2169393
-
Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.Front Neuroendocrinol. 1996 Jan;17(1):1-50. doi: 10.1006/frne.1996.0001. Front Neuroendocrinol. 1996. PMID: 8788568 Review.
-
Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.Ann N Y Acad Sci. 2003 Nov;997:136-49. doi: 10.1196/annals.1290.016. Ann N Y Acad Sci. 2003. PMID: 14644820 Review.
Cited by
-
Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis.PLoS One. 2020 Jan 14;15(1):e0227456. doi: 10.1371/journal.pone.0227456. eCollection 2020. PLoS One. 2020. PMID: 31935235 Free PMC article.
-
Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.J Endocrinol Invest. 1991 Apr;14(4):277-86. doi: 10.1007/BF03346812. J Endocrinol Invest. 1991. PMID: 1650804
MeSH terms
Substances
LinkOut - more resources
Full Text Sources